Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...
Hosted on MSN1mon
Globus Medical strengthens SCS market position with $250m Nevro dealFollowing strong financial results revealed last month, US-headquartered Globus Medical has agreed to acquire spinal cord stimulation (SCS) company Nevro for $250m to reinforce its position in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback